Balance Sheet
Accounts PayablesAccumulated DepreciationAssetsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

60 Degrees Pharmaceuticals (SXTPW) Notes Payables (2022 - 2023)

Historic Notes Payables for 60 Degrees Pharmaceuticals (SXTPW) over the last 2 years, with Q3 2023 value amounting to $2.2 million.

  • 60 Degrees Pharmaceuticals' Notes Payables changed N/A to $2.2 million in Q3 2023 from the same period last year, while for Sep 2023 it was $2.2 million, marking a year-over-year change of. This contributed to the annual value of $16.9 million for FY2022, which is N/A changed from last year.
  • According to the latest figures from Q3 2023, 60 Degrees Pharmaceuticals' Notes Payables is $2.2 million.
  • 60 Degrees Pharmaceuticals' Notes Payables' 5-year high stood at $26.0 million during Q2 2023, with a 5-year trough of $2.2 million in Q3 2023.